Status:

COMPLETED

Transient Ischemic Attack (TIA) Accelerated Diagnostic Protocol

Lead Sponsor:

Corewell Health East

Collaborating Sponsors:

Foundation for Education and Research in Neurological Emergencies

Conditions:

Transient Ischemic Attack

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary objective of this study is to determine if emergency department patients with Transient Ischemic Attack (TIA) that are managed using a TIA "accelerated diagnostic protocol", or "ADP", demo...

Detailed Description

Transient ischemic attack (TIA) is defined as a neurological deficit lasting less than 24 hours, with most lasting less than one hour, brought on by focal cerebral or retinal ischemia. TIAs are common...

Eligibility Criteria

Inclusion

  • Transient ischemic attack confirmed by emergency physician - resolved deficit, not a crescendo TIA.
  • Negative HCT

Exclusion

  • Positive HCT scan for bleed, mass, acute infarct
  • Possible embolic source - A. fib, paroxysmal.A.fib, cardiomyopathy, artificial heart valve, endocarditis, patent foramen ovale, recent MI
  • Known carotid stenosis (\>50%) or mural thrombus
  • Persistent acute neurological deficits
  • Crescendo TIAs
  • Non-focal symptoms - ie confusion, weakness, seizure, transient global amnesia
  • Hypertensive encephalophy / emergency
  • Severe headache or evidence of cranial arteritis
  • Fever
  • Previous stroke
  • Severe dementia
  • Nursing home patient
  • Social issues that make discharge or follow up unlikely
  • Other acute medical problems requiring inpatient admission
  • Patient unlikely to survive beyond study follow up period (90 days)
  • History of IV drug use

Key Trial Info

Start Date :

August 1 2003

Trial Type :

INTERVENTIONAL

End Date :

September 1 2005

Estimated Enrollment :

154 Patients enrolled

Trial Details

Trial ID

NCT00321022

Start Date

August 1 2003

End Date

September 1 2005

Last Update

March 19 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

William Beaumont Hospital

Royal Oak, Michigan, United States, 48073